Brief: Idera Pharmaceuticals Reports Third Quarter Financial Results And Provides Corporate Update

Aceragen

29/10/2020 21:52

Oct 29 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS THIRD QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.59
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES
DATA
    * ANTICIPATE THAT CURRENT CASH, CASH EQUIVALENTS, AND
SHORT-TERM
INVESTMENTS, WILL FUND OPERATIONS THROUGH Q2 OF 2021

Source text for Eikon:  ID:nGNX1H1bQY 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))